EventPilot Web App

Enter Note Done

Go to previous page in this tab

Session

Cardiac Disease Prevention
901 - Basic and Translational Discovery and Innovations in Cardiovascular Disease Prevention

Schedule

Notes

Credits

Moderated Poster Theater 2

Sess#: 901

Set Timezone

Timezone

Allan Klein

Cleveland Clinic Foundation

Arshed Quyyumi

Emory University

Generic 'disconnected' Message

Location: Moderated Poster Theater 2

Session Type: Moderated Poster Contributions

Credit Type - CME: 0; CNE: 0; CNErx: 0; CPE: 0; Dual CME/ABIM MOC: 0; Dual CME/ABP MOC: 0; PA: 0; IPCE: 0; ASRT: 0

Session Type

Pathway

Presentations

Presentation

Cardiac Disease Prevention

DEVELOPMENT OF BRB-002, A NOVEL NEXT-GENERATION ANTI-CD47 MOLECULE, FOR ATHEROSCLEROTIC CARDIOVASCULAR DISEASE - B Alexander Yi

9:30am-9:37am Mar 29 (Central)

B Alexander Yi

Presentation

Cardiac Disease Prevention

Question and Answer

9:37am-9:42am Mar 29 (Central)

Presentation

Cardiac Disease Prevention

ENDOTHELIAL DYSFUNCTION AND INFLAMMATION UP TO A DECADE AFTER PREECLAMPSIA: LASTING EFFECTS BEYOND HYPERTENSION - Odayme Quesada

9:42am-9:49am Mar 29 (Central)

Odayme Quesada

Presentation

Cardiac Disease Prevention

Question and Answer

9:49am-9:54am Mar 29 (Central)

Presentation

Cardiac Disease Prevention

EFFECT OF PLOZASIRAN TARGETING APOC3 ON LIPOPROTEIN PARTICLE NUMBER AND SIZE MEASURED BY NMR IN PATIENTS WITH HYPERTRIGLYCERIDEMIA (HTG) - Christie M. Ballantyne

9:54am-10:01am Mar 29 (Central)

Christie Ballantyne

Presentation

Cardiac Disease Prevention

Question and Answer

10:01am-10:06am Mar 29 (Central)

Presentation

Cardiac Disease Prevention

COMBINATION OF L- AND D-ENANTIOMERS OF AMINO ACIDS LEAD TO GREATER SERUM STABILITY AND ENHANCED IN VIVO TRANSDUCTION BY CARDIAC TARGETING PEPTIDE - Daniella Sahagun

10:06am-10:13am Mar 29 (Central)

Daniella Sahagun

Presentation

Cardiac Disease Prevention

Question and Answer

10:13am-10:18am Mar 29 (Central)

Presentation

Cardiac Disease Prevention

EFFICACY OF A NOVEL CXCR7 AGONIST IN RAT ISCHEMIA REPERFUSION INDUCED MYOCARDIAL INFARCTION MODEL - Yunhee Kim

10:18am-10:25am Mar 29 (Central)

Yunhee Kim

Presentation

Cardiac Disease Prevention

Question and Answer

10:25am-10:30am Mar 29 (Central)

Presentation

Cardiac Disease Prevention

MORE RAPID OXIDATION OF LIPOPROTEIN(A)-ENRICHED PLASMA COMPARED TO SMALL DENSE- AND TRIGLYCERIDE-RICH LIPOPROTEINS IS LIMITED BY EICOSAPENTAENOIC ACID - R. P. Mason

10:30am-10:37am Mar 29 (Central)

R. Mason

Presentation

Cardiac Disease Prevention

Question and Answer

10:37am-10:42am Mar 29 (Central)

Presentation

Cardiac Disease Prevention

ADDITION OF EICOSAPENTAENOIC ACID TO A GLP-1 AGONIST ENHANCED EXPRESSION OF DETOXIFICATION PROTEINS IN ENDOTHELIAL CELLS DURING INFLAMMATION IN VITRO - Samuel C. Sherratt

10:42am-10:49am Mar 29 (Central)

Samuel Sherratt

Presentation

Cardiac Disease Prevention

Question and Answer

10:49am-10:54am Mar 29 (Central)

Presentation

Cardiac Disease Prevention

PREDICTION OF 1-YEAR RECURRENT EVENTS BY TOTAL THROMBUS-FORMATION ANALYSIS AND GLOBAL PLATELET REACTIVITY IN PATIENTS WITH ACS AND STROKE - Kevin Bliden

10:54am-11:01am Mar 29 (Central)

Kevin Bliden

Presentation

Cardiac Disease Prevention

Question and Answer

11:01am-11:06am Mar 29 (Central)

Presentation

Cardiac Disease Prevention

CHARACTERIZATION OF LIPID DROPLETS AND INFLAMMATION IN FOAMY MONOCYTES IN SEVERE HYPERTRIGLYCERIDEMIA - Jing Xiao

11:06am-11:13am Mar 29 (Central)

Jing Xiao

Presentation

Cardiac Disease Prevention

Question and Answer

11:13am-11:18am Mar 29 (Central)

Presentation

Cardiac Disease Prevention

ATORVASTATIN ACTIVE HYDROXYLATED METABOLITES INHIBIT LIPOPROTEIN(A) OXIDATION COMPARED TO OTHER WIDELY USED STATINS - Samuel C. Sherratt

11:18am-11:25am Mar 29 (Central)

Samuel Sherratt

Presentation

Cardiac Disease Prevention

Question and Answer

11:25am-11:30am Mar 29 (Central)